These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3021632)

  • 1. Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis.
    Ivins BE; Welkos SL
    Infect Immun; 1986 Nov; 54(2):537-42. PubMed ID: 3021632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
    Ivins BE; Welkos SL; Knudson GB; Little SF
    Infect Immun; 1990 Feb; 58(2):303-8. PubMed ID: 2105269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.
    Welkos SL; Friedlander AM
    Microb Pathog; 1988 Aug; 5(2):127-39. PubMed ID: 3148815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of recombinant lethal factor of
    Gholami M; Moghbeli M; Kafilzadeh F; Kargar M; Torbati MB; Tavizi A; Bellevile S; Hatami J; Eslami Z
    Prep Biochem Biotechnol; 2021; 51(1):9-15. PubMed ID: 32393098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of a protective antigen-deficient Bacillus anthracis strain.
    Cataldi A; Labruyère E; Mock M
    Mol Microbiol; 1990 Jul; 4(7):1111-7. PubMed ID: 2122174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis.
    Rhie GE; Park YM; Chun JH; Yoo CK; Seong WK; Oh HB
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):331-9. PubMed ID: 16009541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of the protective antigen of Bacillus anthracis in Bacillus subtilis.
    Baillie L; Moir A; Manchee R
    J Appl Microbiol; 1998 May; 84(5):741-6. PubMed ID: 9674126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines.
    Gat O; Inbar I; Aloni-Grinstein R; Zahavy E; Kronman C; Mendelson I; Cohen S; Velan B; Shafferman A
    Infect Immun; 2003 Feb; 71(2):801-13. PubMed ID: 12540560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and expression of the Bacillus anthracis edema factor toxin gene: a calmodulin-dependent adenylate cyclase.
    Tippetts MT; Robertson DL
    J Bacteriol; 1988 May; 170(5):2263-6. PubMed ID: 2834337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cloning and expression of determinants of Bacillus anthracis protective antigen in Escherichia coli, Bacillus subtilis, and Bacillus anthracis cells].
    Tedikov VM; Dobritsa AP
    Mol Gen Mikrobiol Virusol; 1993; (2):13-6. PubMed ID: 8515744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
    Price BM; Liner AL; Park S; Leppla SH; Mateczun A; Galloway DR
    Infect Immun; 2001 Jul; 69(7):4509-15. PubMed ID: 11401993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis.
    Robertson DL; Leppla SH
    Gene; 1986; 44(1):71-8. PubMed ID: 3021591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo.
    Singh Y; Chaudhary VK; Leppla SH
    J Biol Chem; 1989 Nov; 264(32):19103-7. PubMed ID: 2509473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of the protective antigen gene of Bacillus anthracis.
    Vodkin MH; Leppla SH
    Cell; 1983 Sep; 34(2):693-7. PubMed ID: 6413077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity induced by Bacillus anthracis toxin-deficient strains.
    Pezard C; Weber M; Sirard JC; Berche P; Mock M
    Infect Immun; 1995 Apr; 63(4):1369-72. PubMed ID: 7890396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location of receptor-binding region of protective antigen from Bacillus anthracis.
    Little SF; Lowe JR
    Biochem Biophys Res Commun; 1991 Oct; 180(2):531-7. PubMed ID: 1953724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
    Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.